Literature DB >> 9082283

Improving the prediction of visual field progression in glaucoma using spatial processing.

D P Crabb1, F W Fitzke, A I McNaught, D F Edgar, R A Hitchings.   

Abstract

PURPOSE: The authors show how the predictive performance of a method for determining glaucomatous progression in a series of visual fields can be improved by first subjecting the data to a spatial processing technique.
METHOD: Thirty patients with normal-tension glaucoma, each with at least ten Humphrey fields and 3.5 years of follow-up, were included. A linear regression model of sensitivity against time of follow-up determined rates of change at individual test locations over the first five fields (mean follow-up 1.46 years; standard deviation = 0.08) in each field series. Predictions of sensitivity at each location of the field nearest to 1 and 2 years after the fifth field were generated using these rates of change. Predictive performance was evaluated by the difference between the predicted and measured sensitivity values. The analysis was repeated using the same field data subjected to a spatial filtering technique used in image processing.
RESULTS: Using linear modeling of the unprocessed field series, at 1 year after the fifth field, 72% of all predicted values were within +/- 5 dB of the corresponding measured threshold. This prediction precision improved to 83% using the processed data. At the 2-year follow-up field, the predictive performance improved from 56% to 73% with respect to the +/- 5 dB criterion.
CONCLUSIONS: Predictions of visual field progression using a pointwise linear model can be improved by spatial processing without increased cost or patient time. These methods have clinical potential for accurately detecting and forecasting visual field deterioration in the follow-up of glaucoma.

Entities:  

Mesh:

Year:  1997        PMID: 9082283     DOI: 10.1016/s0161-6420(97)30281-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  A spatially varying change points model for monitoring glaucoma progression using visual field data.

Authors:  Samuel I Berchuck; Jean-Claude Mwanza; Joshua L Warren
Journal:  Spat Stat       Date:  2019-02-22

2.  Reducing variability in visual field assessment for glaucoma through filtering that combines structural and functional information.

Authors:  Lisha Deng; Shaban Demirel; Stuart K Gardiner
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-26       Impact factor: 4.799

3.  Comparison of regression models for serial visual field analysis.

Authors:  Jun Mo Lee; Kouros Nouri-Mahdavi; Esteban Morales; Abdelmonem Afifi; Fei Yu; Joseph Caprioli
Journal:  Jpn J Ophthalmol       Date:  2014-08-28       Impact factor: 2.447

4.  The impact of retardance pattern variability on nerve fiber layer measurements over time using GDx with variable and enhanced corneal compensation.

Authors:  Dilraj S Grewal; Mitra Sehi; Richard J Cook; David S Greenfield
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-23       Impact factor: 4.799

5.  Reducing Variability of Perimetric Global Indices from Eyes with Progressive Glaucoma by Censoring Unreliable Sensitivity Data.

Authors:  Manoj Pathak; Shaban Demirel; Stuart K Gardiner
Journal:  Transl Vis Sci Technol       Date:  2017-07-20       Impact factor: 3.283

6.  Detecting changes in retinal function: Analysis with Non-Stationary Weibull Error Regression and Spatial enhancement (ANSWERS).

Authors:  Haogang Zhu; Richard A Russell; Luke J Saunders; Stefano Ceccon; David F Garway-Heath; David P Crabb
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

7.  Enhancement of Visual Field Predictions with Pointwise Exponential Regression (PER) and Pointwise Linear Regression (PLR).

Authors:  Esteban Morales; John Mark S de Leon; Niloufar Abdollahi; Fei Yu; Kouros Nouri-Mahdavi; Joseph Caprioli
Journal:  Transl Vis Sci Technol       Date:  2016-03-14       Impact factor: 3.283

8.  Visual Subfield Progression in Glaucoma Subtypes.

Authors:  Wei-Wen Su; Shian-Sen Hsieh; Shih-Tsung Cheng; Cheng-Wen Su; Wei-Chi Wu; Henry Shen-Lih Chen
Journal:  J Ophthalmol       Date:  2018-03-21       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.